Atea Pharmaceuticals, Inc. (AVIR)

4.65 +0.06 (+1.31%) USD  |  NASDAQ  |  Feb 24, 16:00
4.66 +0.01 (+0.22%) After-Hours: 20:00
More

Atea Pharmaceuticals Operating Income (Quarterly)

Operating Income (Quarterly) Chart

View Operating Income (Quarterly) for AVIR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly) Range, Past 5 Years

View Operating Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly) Benchmarks

View Operating Income (Quarterly) Benchmarks
Start Trial
Oramed Pharmaceuticals, Inc. Upgrade
Aclaris Therapeutics, Inc. Upgrade
PMV Pharmaceuticals, Inc. Upgrade
Instil Bio, Inc. Upgrade
Coya Therapeutics, Inc. Upgrade